We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Pilot Seeks to Improve Postmarket Safety Data
The European Medicines Agency is launching a 12-month pilot program to improve the usefulness of postmarket safety data by giving drugmakers targeted advice on postmarket study design.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor